[{"Assets_0_FY_USD":11035000.0,"CommonStockSharesOutstanding_0_FY_shares":24571029.0,"EarningsPerShareBasic_4_FY_USD":-0.99,"EarningsPerShareDiluted_4_FY_USD":-0.99,"NetIncomeLoss_4_FY_USD":-26414000.0,"StockholdersEquity_0_FY_USD":-11268000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":22669819.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":22669819.0,"Ticker":"OCGN","CIK":"1372299","name":"HISTOGENICS CORP","OfficialName":"Ocugen Inc. Common Stock","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"583661968.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180315"}]